425: PowerUp Acquisition Corp. and Aspire Biopharma Extend Disclosure Schedule Deadline in Merger Agreement

PowerUp Acquisition Corp. and Aspire Biopharma agree to extend the deadline for delivering disclosure schedules as part of their merger agreement to allow for additional due diligence.

Summary

• PowerUp Acquisition Corp. and Aspire Biopharma have amended their merger agreement to extend the Disclosure Schedule Delivery Date to October 11, 2024.
• The decision to extend the deadline was made to allow both parties additional time to complete their ongoing diligence reviews and compile their respective disclosure schedules.
• This is the second amendment to the original merger agreement, which was initially signed on August 26, 2024.
• The first amendment, dated September 5, 2024, adjusted the merger consideration and the size of the equity incentive plan, and provided additional time for due diligence.
• Failure to cure any items set forth in Disclosure Issue Notice shall allow the non-disclosing Party to terminate this Agreement pursuant to Section 7.1(i).

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the extension of the deadline introduces a slight delay, it also indicates a commitment to thorough due diligence. The document contains standard forward-looking statements and risk disclosures.

Positives

• The extension of the deadline suggests that both parties are committed to thorough due diligence, which could lead to a more informed and successful merger.
• The parties are working together to resolve any issues that may arise during the due diligence process.

Negatives

• The need for a second amendment may indicate potential complexities or issues that require further investigation.
• The extension introduces a slight delay in the timeline for the completion of the merger.

Risks

• The forward-looking statements included in the report are subject to various risks and uncertainties that could cause actual results to differ materially.
• These risks include the possibility that the merger may not be completed in a timely manner or at all, failure to meet Nasdaq listing standards, and changes in market conditions.
• There are also risks related to Aspire's ability to execute its growth strategies and manage its operations effectively.
• The potential for shareholder redemptions exceeding anticipated levels could impact the financial condition of the combined company.
• Failure to cure any items set forth in Disclosure Issue Notice shall allow the non-disclosing Party to terminate this Agreement pursuant to Section 7.1(i).

Future Outlook

The document contains forward-looking statements regarding the anticipated benefits and timing of the proposed business combination, as well as the future financial condition and performance of Aspire and the combined company. However, these statements are subject to various risks and uncertainties.

Management Comments

• The parties agreed it is in their best collective interests to allow for additional time to complete their on-going diligence reviews and the compilation of their respective disclosure schedules.

Industry Context

SPAC mergers are subject to intense scrutiny and require thorough due diligence. Extending deadlines for disclosure schedules is not uncommon, especially when dealing with complex transactions or novel technologies.

Comparison to Industry Standards

• The extension of the disclosure schedule delivery date is not unusual in SPAC transactions, as thorough due diligence is critical.
• Other SPAC deals, such as the merger of Digital World Acquisition Corp. and Trump Media & Technology Group, have also faced delays due to regulatory scrutiny and due diligence requirements.
• Compared to industry benchmarks, the timeline for this merger appears to be within the typical range for SPAC transactions, although any further delays could raise concerns.

Stakeholder Impact

• Shareholders of PowerUp will need to approve the Business Combination Agreement.
• The completion of the merger will impact the future operations and financial performance of both PowerUp and Aspire.
• Employees of Aspire may be affected by changes in management or operations following the merger.

Next Steps

• The parties will complete their due diligence reviews and compile their respective disclosure schedules.
• The Company and Purchaser will review the disclosing Party's disclosure schedules and notify the disclosing Party of any item listed or omitted on the disclosure schedule that has a material impact on the non-disclosing Party's willingness or ability to consummate the Transaction.
• The disclosing Party shall cure the items set forth in Disclosure Issue Notice within seven (7) calendar days following receipt of the Disclosure Issue Notice.
• PowerUp will file a proxy statement with the SEC and mail it to shareholders for voting on the proposed Business Combination.

Key Dates